Evidence map›Paper›PMID 31142178›Full record

ArticleJournal of the American Heart Association2019

Echocardiographic Abnormalities and Determinants of 1-Month Outcome of Stroke Among West Africans in the SIREN Study.

Abiodun M Adeoye, Bruce Ovbiagele, Joshua O Akinyemi, Okechukwu S Ogah, Rufus Akinyemi, Mulugeta Gebregziabher, Kolawole Wahab, Adekunle G Fakunle, Adeseye Akintunde, Oladimeji Adebayo and 18 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 15 institutions in 3 countries.

Abiodun M Adeoye1 Center for Genomic and Precision Medicine University of Ibadan Ibadan Nigeria.
Bruce Ovbiagele2 Department of Neurology University of California San Francisco CA.
Joshua O Akinyemi3 University of Ibadan Ibadan Nigeria.
Okechukwu S Ogah3 University of Ibadan Ibadan Nigeria.
Rufus Akinyemi4 Federal Medical Centre Abeokuta Nigeria.
Mulugeta Gebregziabher5 Medical University of South Carolina Charleston SC.
Kolawole Wahab6 University of Ilorin Ilorin Nigeria.
Adekunle G Fakunle3 University of Ibadan Ibadan Nigeria.
Adeseye Akintunde7 Ladoke Akintola University of Technology Ogbomoso Nigeria.
Oladimeji Adebayo8 University College Hospital Ibadan Nigeria.
Akinyemi Aje8 University College Hospital Ibadan Nigeria.
Hemant K Tiwari9 University of Alabama at Birmingham Birmingham AL.
Donna Arnett10 University of Kentucky at Lexington KY.
Francis Agyekum11 University of Ghana Medical School Accra Ghana.
Lambert T Appiah12 Komfo Anokye Teaching Hospital Kumasi Ghana.
Ganiyu Amusa13 Jos University Teaching Hospital Jos Nigeria.
Taiwo O Olunuga4 Federal Medical Centre Abeokuta Nigeria.
Akpa Onoja3 University of Ibadan Ibadan Nigeria.
Fred S Sarfo12 Komfo Anokye Teaching Hospital Kumasi Ghana.
Albert Akpalu11 University of Ghana Medical School Accra Ghana.
Carolyn Jenkins5 Medical University of South Carolina Charleston SC.
Daniel Lackland5 Medical University of South Carolina Charleston SC.
Lukman Owolabi14 Aminu Kano Teaching Hospital Kano Nigeria.
Morenikeji Komolafe15 Obafemi Awolowo University Teaching Hospital Ile-Ife Nigeria.
Moyinoluwalogo M Faniyan3 University of Ibadan Ibadan Nigeria.
Oyedunni Arulogun3 University of Ibadan Ibadan Nigeria.
Reginald Obiako16 Ahmadu Bello University Zaria Nigeria.
Mayowa Owolabi1 Center for Genomic and Precision Medicine University of Ibadan Ibadan Nigeria.
University of Ibadan · NGMedical University of South Carolina · USFederal Medical Centre · NGKomfo Anokye Teaching Hospital · GHUniversity College Hospital, Ibadan · NGUniversity of Ghana · GHAhmadu Bello University · NGAminu Kano Teaching Hospital · NGJos University Teaching Hospital · NGLadoke Akintola University of Technology · NGObafemi Awolowo University · NGUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of Ilorin · NGUniversity of Kentucky · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
Stroke Investigative Research & Educational Network (SIREN)U54HG007479 · NHGRI · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI OVBIAGELE, BRUCE, OWOLABI, MAYOWA OJO · 2013 to 2017
$4.2M
Systematic Investigation of Blacks with Stroke - Genomics (SIBS-Genomics) StudyR01NS107900 · NINDS · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI OVBIAGELE, BRUCE, OWOLABI, MAYOWA OJO · 2018 to 2021
$1.8M
NHGRI NIH HHS U54 HG007479NIDDK NIH HHS P30 DK079626NINDS NIH HHS R01 NS107900
6 · The paper itself

Abstract

Background Little is known about the relationship between echocardiographic abnormalities and outcome among patients with acute stroke. We investigated the pattern and association of baseline echocardiographic variables with 1-month disability and mortality among patients with stroke in the SIREN (Stroke Investigative Research and Education Network) study. Methods and Results We enrolled and followed up consecutive 1020 adult patients with acute stroke with baseline transthoracic echocardiography from west Africa. To explore the relationship between echocardiographic variables and 1-month disability (using modified Rankin scale >3) and fatality, regression models were fitted. Relative risks were computed with 95% CIs. The participants comprised 60% men with a mean age of 59.2±14.6 years. Ischemic stroke was associated with smaller aortic root diameter (30.2 versus 32.5, P=0.018) and septal (16.8 versus 19.1, P<0.001) and posterior wall thickness at systole (18.9 versus 21.5, P=0.004). Over 90% of patients with stroke had abnormal left ventricular (LV) geometry with eccentric hypertrophy predominating (56.1%). Of 13 candidate variables investigated, only baseline abnormal LV geometry (concentric hypertrophy) was weakly associated with 1-month disability (unadjusted relative risk, 1.80; 95% CI , 0.97-5.73). Severe LV systolic dysfunction was significantly associated with increased 1-month mortality (unadjusted relative risk, 3.05; 95% CI , 1.36-6.83). Conclusions Nine of 10 patients with acute stroke had abnormal LV geometry and a third had systolic dysfunction. Severe LV systolic dysfunction was significantly associated with 1 month mortality. Larger studies are required to establish the independent effect and unravel predictive accuracy of this association.

Indexed as

EchocardiographyVentricular Function, LeftVentricular RemodelingAdultAgedBlack PeopleCase-Control StudiesDisability EvaluationFemaleGhanaHumansHypertrophy, Left VentricularMaleMiddle AgedNigeriaPredictive Value of Testsechocardiographyleft ventricular geometrymorbidity/mortalitystroke

Identifiers

PMID31142178
PMCPMC6585359
OpenAlexW2947734797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.